About HKTDC | Media Room | Contact HKTDC | Wish List Wish List () | My HKTDC |
繁體 简体
Save As PDF Print this page

China Determines to Regulate Supply and Cost of Commonly-Used Medicines

The 16 August Executive Meeting of the State Council approved four measures designed to maintain the supply of commonly-required medicines, while also more effectively regulating the related costs:

  1. Streamlining and enhancing the existing drug procurement system
  2. Improving the management of drugs in medical institutions by giving priority to the use of those deemed essential
  3. Putting in place a monitoring and fast response facility to keep track of which drugs are in short supply and to ensure prompt remedial action is initiated
  4. Enhancing the oversight of drug prices and ensuring cost controls are properly enforced

Source: State Council of China

Content provided by Picture: HKTDC Research
Comments (0)
Shows local time in Hong Kong (GMT+8 hours)

HKTDC welcomes your views. Please stay on topic and be respectful of other readers.
Review our Comment Policy

*Add a comment (up to 5,000 characters)